The Menopause Society | Menopause Society Certified Practitioner
Menopause Society Certified Practitioner
Examination 2026/2027 | Verified Questions
The Menopause Society | Menopause Society Certified Practitioner | Professional Menopause Practitioner
Candidates
100 Verified Questions | 6 Core Domains | Academic Year 2026/2027
Prepared by
The Menopause Society | Menopause Society Certified Practitioner
MSCP Certification Examination Actual Exam | Academic Year 2026/2027
Menopause Society Certified Practitioner Examination 2026/2027 | Verified Questions
,INTRODUCTION
This document contains 100 original Verified Questions covering the full Menopause Society Certified
Practitioner (MSCP) Certification Examination for the academic year 2026/2027. The content addresses
every core domain of the official MSCP content outline: Domain 1 – Physiology & Pathophysiology of the
Menopause Transition; Domain 2 – Symptoms & Concerns of Menopause; Domain 3 – Health Disorders
in Midlife Women; Domain 4 – Therapeutic Options; Domain 5 – Preventive Care & Counseling; and
Domain 6 – Comprehensive Review & Special Populations. Each question is designed to reinforce official
Menopause Society guidelines, STRAW+10 staging criteria, and the clinical competencies required for
professional-level menopause care.
ACTUAL QUESTIONS
Domain 1: Physiology & Pathophysiology of the Menopause Transition
Question 1. According to STRAW+10, the early menopause transition is characterized by:
A. ≥60 days of amenorrhea
B. A persistent difference of ≥7 days in consecutive menstrual cycle lengths
C. Complete cessation of menses for 12 months
D. Elevated FSH only without cycle changes
Correct Answer: B
Rationale: STRAW+10 defines the early menopause transition by a persistent ≥7-day difference in
consecutive cycle lengths.
Question 2. STRAW+10 defines the late menopause transition by:
A. Occasional skipped cycles only
B. Regular cycles with elevated AMH
C. Hot flashes without cycle change
D. Amenorrhea of ≥60 days
Correct Answer: D
Rationale: The late menopause transition is marked by amenorrhea lasting ≥60 days.
Question 3. Early menopause is defined as the final menstrual period occurring before age:
A. 45
B. 40
C. 50
D. 55
Correct Answer: A
Rationale: Early menopause is the final menstrual period before age 45; premature ovarian
insufficiency occurs before age 40.
Question 4. Premature ovarian insufficiency (POI) is defined as loss of ovarian function
before age:
A. 35
B. 45
C. 40
D. 50
Correct Answer: C
Rationale: POI is the loss of ovarian activity before age 40.
Question 5. When evaluating premature ovarian insufficiency, the clinician should:
Menopause Society Certified Practitioner Examination 2026/2027 | Verified Questions
, A. Ignore laboratory and clinical findings
B. Rely exclusively on a single laboratory value
C. Postpone all discussion until after age 65
D. Integrate patient history, examination, and evidence-based guidelines to guide recommendations
Correct Answer: D
Rationale: Evidence-based menopause care requires integration of clinical findings and guidelines
when addressing premature ovarian insufficiency.
Question 6. A key principle related to late menopause definition is that:
A. Individualized assessment and shared decision-making improve outcomes
B. No intervention is ever indicated
C. All women require identical therapy
D. Symptoms should be dismissed as normal aging only
Correct Answer: A
Rationale: Individualized assessment and shared decision-making are central to high-quality care
involving late menopause definition.
Question 7. Which statement best reflects current evidence regarding AMH ovarian
reserve marker?
A. It has no clinical relevance in midlife women
B. It applies only to women over age 70
C. It is an important consideration in the assessment and management of the menopause transition
D. It is determined solely by patient preference without clinical data
Correct Answer: C
Rationale: Current Menopause Society guidance identifies AMH ovarian reserve marker as a clinically
relevant factor that should inform assessment and individualized management during the menopause
transition.
Question 8. When evaluating follicle-stimulating hormone changes, the clinician should:
A. Ignore laboratory and clinical findings
B. Integrate patient history, examination, and evidence-based guidelines to guide recommendations
C. Rely exclusively on a single laboratory value
D. Postpone all discussion until after age 65
Correct Answer: B
Rationale: Evidence-based menopause care requires integration of clinical findings and guidelines
when addressing follicle-stimulating hormone changes.
Question 9. A key principle related to estradiol decline patterns is that:
A. No intervention is ever indicated
B. All women require identical therapy
C. Symptoms should be dismissed as normal aging only
D. Individualized assessment and shared decision-making improve outcomes
Correct Answer: D
Rationale: Individualized assessment and shared decision-making are central to high-quality care
involving estradiol decline patterns.
Question 10. Which statement best reflects current evidence regarding inhibin B changes?
A. It is an important consideration in the assessment and management of the menopause transition
B. It has no clinical relevance in midlife women
C. It applies only to women over age 70
Menopause Society Certified Practitioner Examination 2026/2027 | Verified Questions
Menopause Society Certified Practitioner
Examination 2026/2027 | Verified Questions
The Menopause Society | Menopause Society Certified Practitioner | Professional Menopause Practitioner
Candidates
100 Verified Questions | 6 Core Domains | Academic Year 2026/2027
Prepared by
The Menopause Society | Menopause Society Certified Practitioner
MSCP Certification Examination Actual Exam | Academic Year 2026/2027
Menopause Society Certified Practitioner Examination 2026/2027 | Verified Questions
,INTRODUCTION
This document contains 100 original Verified Questions covering the full Menopause Society Certified
Practitioner (MSCP) Certification Examination for the academic year 2026/2027. The content addresses
every core domain of the official MSCP content outline: Domain 1 – Physiology & Pathophysiology of the
Menopause Transition; Domain 2 – Symptoms & Concerns of Menopause; Domain 3 – Health Disorders
in Midlife Women; Domain 4 – Therapeutic Options; Domain 5 – Preventive Care & Counseling; and
Domain 6 – Comprehensive Review & Special Populations. Each question is designed to reinforce official
Menopause Society guidelines, STRAW+10 staging criteria, and the clinical competencies required for
professional-level menopause care.
ACTUAL QUESTIONS
Domain 1: Physiology & Pathophysiology of the Menopause Transition
Question 1. According to STRAW+10, the early menopause transition is characterized by:
A. ≥60 days of amenorrhea
B. A persistent difference of ≥7 days in consecutive menstrual cycle lengths
C. Complete cessation of menses for 12 months
D. Elevated FSH only without cycle changes
Correct Answer: B
Rationale: STRAW+10 defines the early menopause transition by a persistent ≥7-day difference in
consecutive cycle lengths.
Question 2. STRAW+10 defines the late menopause transition by:
A. Occasional skipped cycles only
B. Regular cycles with elevated AMH
C. Hot flashes without cycle change
D. Amenorrhea of ≥60 days
Correct Answer: D
Rationale: The late menopause transition is marked by amenorrhea lasting ≥60 days.
Question 3. Early menopause is defined as the final menstrual period occurring before age:
A. 45
B. 40
C. 50
D. 55
Correct Answer: A
Rationale: Early menopause is the final menstrual period before age 45; premature ovarian
insufficiency occurs before age 40.
Question 4. Premature ovarian insufficiency (POI) is defined as loss of ovarian function
before age:
A. 35
B. 45
C. 40
D. 50
Correct Answer: C
Rationale: POI is the loss of ovarian activity before age 40.
Question 5. When evaluating premature ovarian insufficiency, the clinician should:
Menopause Society Certified Practitioner Examination 2026/2027 | Verified Questions
, A. Ignore laboratory and clinical findings
B. Rely exclusively on a single laboratory value
C. Postpone all discussion until after age 65
D. Integrate patient history, examination, and evidence-based guidelines to guide recommendations
Correct Answer: D
Rationale: Evidence-based menopause care requires integration of clinical findings and guidelines
when addressing premature ovarian insufficiency.
Question 6. A key principle related to late menopause definition is that:
A. Individualized assessment and shared decision-making improve outcomes
B. No intervention is ever indicated
C. All women require identical therapy
D. Symptoms should be dismissed as normal aging only
Correct Answer: A
Rationale: Individualized assessment and shared decision-making are central to high-quality care
involving late menopause definition.
Question 7. Which statement best reflects current evidence regarding AMH ovarian
reserve marker?
A. It has no clinical relevance in midlife women
B. It applies only to women over age 70
C. It is an important consideration in the assessment and management of the menopause transition
D. It is determined solely by patient preference without clinical data
Correct Answer: C
Rationale: Current Menopause Society guidance identifies AMH ovarian reserve marker as a clinically
relevant factor that should inform assessment and individualized management during the menopause
transition.
Question 8. When evaluating follicle-stimulating hormone changes, the clinician should:
A. Ignore laboratory and clinical findings
B. Integrate patient history, examination, and evidence-based guidelines to guide recommendations
C. Rely exclusively on a single laboratory value
D. Postpone all discussion until after age 65
Correct Answer: B
Rationale: Evidence-based menopause care requires integration of clinical findings and guidelines
when addressing follicle-stimulating hormone changes.
Question 9. A key principle related to estradiol decline patterns is that:
A. No intervention is ever indicated
B. All women require identical therapy
C. Symptoms should be dismissed as normal aging only
D. Individualized assessment and shared decision-making improve outcomes
Correct Answer: D
Rationale: Individualized assessment and shared decision-making are central to high-quality care
involving estradiol decline patterns.
Question 10. Which statement best reflects current evidence regarding inhibin B changes?
A. It is an important consideration in the assessment and management of the menopause transition
B. It has no clinical relevance in midlife women
C. It applies only to women over age 70
Menopause Society Certified Practitioner Examination 2026/2027 | Verified Questions
